Credit: NIAID A Phase 2/3 trial to evaluate a new fully-human polyclonal antibody therapeutic targeted to SARS-CoV-2, called SAB-185, has begun enrolling non-hospitalized people with mild...
TORONTO – New Leaf Canada Inc. reported it has received approval from Health Canada that will allow its wholly-owned subsidiary Psirenity to begin construction of a...
Credit: College of Engineering & Applied Science, University of Colorado Boulder When disease outbreaks happen, response time in developing and distributing treatments is crucial to saving...
Canada's pharmaceutical industry is a key contributor to the global pharma market. Here are the top Canadian pharma stocks of 2021. The post Top Canadian Pharma...
BioElectronics Corp. (OTCPINK: BIEL) is heating up again in recent trading and looking to break out northbound again. Microcapdaily has been reporting on BIEL for years and covered them...
Less than a month after submitting an Investigational New Drug (IND) application, Anixa Biosciences ran into a snag with the U.S. Food and Drug Administration as the government...
Sixth Wave Innovations (SIXW.C) entered into a non-binding letter of intent (LOI) with Halucenex Life Sciences, a soon to be wholly-owned subsidiary of Cresco Pharma. According...
Sixth Wave Innovations (SIXW.C) entered into a non-binding letter of intent (LOI) with Halucenex Life Sciences, a soon to be wholly-owned subsidiary of Cresco Pharma. According...
Acting FDA Commissioner Janet Woodcock shared her thoughts on pandemic issues and outlined FDA modernization plans in a Q&A session with the Alliance for a Stronger...
Acting FDA Commissioner Janet Woodcock shared her thoughts on pandemic issues and outlined FDA modernization plans in a Q&A session with the Alliance for a Stronger...